Author:
Furst D. E.,Clements P. J.,Wong W. K.,Mayes M. D.,Wigley F.,White B.,Weisman M.,Barr W.,Moreland L.,Martin R.,Medsger T. A.,Steen V.,Collier D.,Weinstein A.,Lally E.,Varga J.,Weiner S. R.,Andrews B.,Abeles M.,Peter J. B.,Seibold J. R.
Publisher
Oxford University Press (OUP)
Subject
Pharmacology (medical),Rheumatology
Reference46 articles.
1. Seibold JR, Furst DE, Clements PJ. Treatment of systemic sclerosis by disease‐modifying agents. In: Clements PJ, Furst DE, eds. Systemic sclerosis. Baltimore: Williams & Wilkins,1996:535–48.
2. Seibold JR, Furst DE, Clements PJ. Why everything (or nothing) seems to work in the treatment of scleroderma [editorial]. J Rheumatol1992;19:673–6.
3. White B, Bauer EA, Goldsmith LA et al. Guidelines for clinical trials in systemic sclerosis (scleroderma). I. Disease‐modifying interventions. The American College of Rheumatology committee on design and outcomes in clinical trials in systemic sclerosis. Arthritis Rheum1995;38:351–60.
4. Clements PJ, Furst DE, Wong WK et al. High dose vs. low dose penicillamine in early diffuse systemic sclerosis trial: analysis of a two‐year, double‐blind, randomized controlled clinical treatment trial. Arthritis Rheum1999; 42:1194–203.
5. Morris JF, Koski A, Johnson LC. Spirometric standard for healthy non‐smoking adults. Am Rev Respir Dis1971; 103:57–67.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献